+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemostasis Products - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806485
The global market for Hemostasis Products was valued at US$14.3 Billion in 2024 and is projected to reach US$17.9 Billion by 2030, growing at a CAGR of 3.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Hemostasis Products market.

Global Hemostasis Products Market - Key Trends & Drivers Summarized

How Are Hemostasis Products Essential in Surgical and Trauma Care?

Hemostasis products are vital in controlling bleeding during surgeries and trauma situations, ensuring patient safety and minimizing complications. These products, which include topical agents, sealants, and hemostatic dressings, provide immediate bleeding control, allowing surgeons to perform procedures more safely. In emergency trauma care, hemostasis products are essential for preventing excessive blood loss, improving survival rates in critical cases. As surgical procedures and trauma cases increase worldwide, demand for reliable and effective hemostasis solutions is growing.

Why Is Demand for Advanced Hemostasis Solutions Increasing?

Demand for advanced hemostasis solutions is on the rise, as healthcare providers seek products that offer faster and more effective bleeding control. Innovations such as fibrin sealants, collagen-based dressings, and recombinant thrombin provide enhanced clotting capabilities, reducing surgical time and improving patient outcomes. Minimally invasive surgeries also require hemostasis products with precise application, driving demand for advanced solutions. As healthcare systems prioritize efficiency and patient safety, advanced hemostasis products are becoming essential in modern surgical care.

What Role Does Regulatory Approval Play in Hemostasis Product Adoption?

Regulatory approval is crucial in the hemostasis products market, as safety and efficacy are paramount for products used in critical bleeding control. Regulatory agencies such as the FDA and EMA ensure that hemostasis products meet stringent quality standards, requiring rigorous clinical testing. Approved products gain greater trust and are more widely adopted in healthcare settings, making regulatory compliance a key factor in market success. With healthcare facilities prioritizing safe and effective products, regulatory-approved hemostasis solutions are essential for maintaining quality standards in patient care.

What Drives the Growth of the Hemostasis Products Market?

The growth in the hemostasis products market is driven by increasing surgical procedures, demand for advanced bleeding control solutions, and strict regulatory standards. Rising surgical volumes and trauma cases are fueling demand for effective hemostasis products in healthcare settings. Advances in product design, such as fast-acting sealants and enhanced clotting agents, support better patient outcomes, making them indispensable in operating rooms. Additionally, regulatory requirements for product safety and efficacy further support market growth, positioning hemostasis products as essential tools in critical and routine surgical care.

Report Scope

The report analyzes the Hemostasis Products market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Product (Infusible Hemostasis, Topical Hemostasis, Advanced Hemostasis); Application (Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke, Thrombosis).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Infusible Hemostasis segment, which is expected to reach US$8.6 Billion by 2030 with a CAGR of a 3.4%. The Topical Hemostasis segment is also set to grow at 3.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $3.9 Billion in 2024, and China, forecasted to grow at an impressive 6.2% CAGR to reach $3.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Hemostasis Products Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Hemostasis Products Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Hemostasis Products Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Inc., BARD, A Becton, Dickinson Company, Baxter International, Inc., CSL Behring, Grifols SA and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 46 companies featured in this Hemostasis Products market report include:

  • Abbott Laboratories, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • CSL Behring
  • Grifols SA
  • Integra Life Sciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Impact of COVID-19 and a Looming Global Recession
  • Hemostasis Products - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Effective Bleeding Control Solutions in Trauma Care
  • Growth in Hemostatic Agents and Dressings for Surgical Use
  • Increasing Adoption of Topical Hemostats in Outpatient Settings
  • Expansion of Hemostasis Products in Dental and Orthopedic Procedures
  • Higher Demand for Advanced Wound Care Products in Hemostasis
  • Development of Biocompatible and Fast-Acting Hemostatic Products
  • Increased Use of Hemostatic Dressings in Military and Emergency Care
  • Growth in Demand for Hemostasis Products in Oncology and Critical Care
  • Expansion of Hemostatic Agents in Minimally Invasive Surgeries
  • Growth of E-commerce Platforms Offering Hemostatic Products
  • Rising Adoption of Hemostasis Products in Sports Medicine
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Hemostasis Products Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Infusible Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Topical Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Advanced Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Hemophilia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Myocardial Infarction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 30: World Historic Review for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: World 15-Year Perspective for Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 32: USA Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 33: USA Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 34: USA 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 35: USA Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 36: USA Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 37: USA 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
CANADA
  • Table 38: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 40: Canada 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: Canada 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
JAPAN
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 44: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 46: Japan 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 47: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 49: Japan 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
CHINA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 50: China Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 51: China Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 52: China 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 53: China Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 54: China Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 55: China 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
EUROPE
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 56: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 58: Europe 15-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 61: Europe 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 64: Europe 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
FRANCE
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 65: France Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 66: France Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 67: France 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 68: France Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 69: France Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 70: France 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
GERMANY
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 71: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 73: Germany 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 74: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 75: Germany Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 76: Germany 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
ITALY
  • Table 77: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 79: Italy 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 80: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 81: Italy Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 82: Italy 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 83: UK Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 84: UK Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 85: UK 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 86: UK Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 87: UK Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 88: UK 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
SPAIN
  • Table 89: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 90: Spain Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 91: Spain 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 92: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 93: Spain Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 94: Spain 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
RUSSIA
  • Table 95: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 96: Russia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 97: Russia 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 98: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 99: Russia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 100: Russia 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 103: Rest of Europe 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 104: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 105: Rest of Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 106: Rest of Europe 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 109: Asia-Pacific 15-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 111: Asia-Pacific Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 112: Asia-Pacific 15-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2015, 2025 & 2030
  • Table 113: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 114: Asia-Pacific Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 115: Asia-Pacific 15-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2015, 2025 & 2030
AUSTRALIA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • CSL Behring
  • Grifols SA
  • Integra Life Sciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.

Table Information